Results 191 to 200 of about 64,774 (217)

Efficacy and Safety of Nanoencapsulated Sirolimus Plus Pegadricase: Results From the Randomized, Placebo‐Controlled Phase 3 Trials

open access: yesArthritis &Rheumatology, EarlyView.
Objective DISSOLVE I and II examined the efficacy and safety of nanoencapsulated sirolimus (NAS) plus pegadricase (NASP) in patients with uncontrolled gout (UG). Methods In these double‐blind, placebo‐controlled Phase 3 trials of NASP, patients were randomized 1:1:1 to infusions of high‐dose (HD) or low‐dose (LD) NAS plus pegadricase (HD NASP, LD NASP,
Herbert S. B. Baraf   +15 more
wiley   +1 more source

Adapting a U.S.-based micro-savings program for Uganda: implementation process and lessons learned. [PDF]

open access: yesChild Youth Serv Rev
Namuwonge F   +7 more
europepmc   +1 more source

Esophageal adenosquamous carcinoma with mucinous carcinoma-predominant lymph node metastases: a case report. [PDF]

open access: yesGen Thorac Cardiovasc Surg Cases
Maeda N   +12 more
europepmc   +1 more source

Centering the voices of young people who use opioids and youth harm reduction practitioners: insights from an international Youth RISE cohort. [PDF]

open access: yesHarm Reduct J
Juristia A   +7 more
europepmc   +1 more source

Sustainable development and financial institutions: Do banks' environmental policies influence customer deposits?

Business Strategy and the Environment, 2021
Simona Galletta   +2 more
exaly  

Does the deposit channel of monetary policy work in a high-interest rate environment?

Journal of Banking and Finance, 2022
Fabio Garcia   +1 more
exaly  

Home - About - Disclaimer - Privacy